KHDRBS1 and prostate carcinoma: The subcellular localization of SAM68 and other RBPs was affected by treatment of prostate cancer cells with mitoxantrone (MTX), a topoisomerase II inhibitor used in chemotherapy, partially altering the cellular AS pattern [119].